B. Riley reported on Transenterix Inc (NYSE:TRXC), upping its stock price target to $3.00 earlier today
- Updated: October 7, 2016
B. Riley raised the price target of Transenterix Inc (NYSE:TRXC) to $3.00 reporting a possible upside of 0.63%.
Previously on Wednesday May 11, 2016, Lake Street reported on Transenterix Inc (NYSE:TRXC) increased the target price from $0.00 to $2.00. At the time, this indicated a possible upside of 0.29%.
Just yesterday Transenterix Inc (NYSE:TRXC) traded -0.58% lower at $1.84. Transenterix Inc’s 50-day moving average is $1.51 and its 200-day moving average is $2.04. The last closing price is down -16.36% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 324,534 shares of TRXC traded hands, down from an average trading volume of 733,826
Recent Performance Chart
Transenterix Inc has 52 week low of $1.03 and a 52 week high of $6.10 and has a market capitalization of $0.
In addition to B. Riley reporting its stock price target, a total of 7 brokers have issued a research note on the company. The average stock price target is $4.04 with 3 brokers rating the stock a strong buy, 4 brokers rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
Brief Synopsis On Transenterix Inc (NYSE:TRXC)
TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.